After years of being labeled “uninvestable,” China’s stock markets are once again attracting significant foreign investment, driven by a renewed focus on the country’s innovation in the AI, semiconductor, and biotech sectors.
A US-China tariff truce and supportive domestic monetary policies have bolstered investor confidence, helping the Shanghai Composite index reach a decade-high. This bullish sentiment is also fueled by a growing need for portfolio diversification beyond U.S. assets, as investors are increasingly viewing China as a unique, uncorrelated asset class.
Data from Morgan Stanley shows August saw the largest monthly buying of Chinese stocks by global hedge funds in six months, while Morningstar notes a sharp decline in new “emerging market ex-China” fund launches. Firms like London-based Polar Capital have increased their allocation to China, citing the country’s revaluation of innovative assets. However, challenges persist, including weakness in factory output and retail sales, and ongoing deflationary pressures.
Despite these concerns, foreign capital is in a “rerating” phase, with many allocators planning trips to explore opportunities, suggesting a cautious but definitive shift in sentiment. The revival of interest highlights the evolving dynamics of global finance, with China’s resilience and technological advances playing a crucial role.
